|
[1]
|
Sorokin, I., Mamoulakis, C., Miyazawa, K., Rodgers, A., Talati, J. and Lotan, Y. (2017) Epidemiology of Stone Disease across the World. World Journal of Urology, 35, 1301-1320. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Kachkoul, R., Touimi, G.B., El Mouhri, G., et al. (2023) Urolithiasis: History, Epidemiology, Aetiologic Factors and Management. Malaysian Journal of Pathology, 45, 333-352.
|
|
[3]
|
Yitgin, Y., Asrak, H. and Tefik, T. (2023) Role, Importance and Assessment of Dietary Habits in Urolithiasis Patient. World Journal of Urology, 41, 1229-1233. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Lehrer, S., Morello, T., Karrasch, C., Rheinstein, P.H. and Danias, J. (2024) Effect of Glucosamine on Intraocular Pressure and Risk of Developing Glaucoma. Journal of Glaucoma, 33, 240-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Derwich, M., Górski, B., Amm, E. and Pawłowska, E. (2023) Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review. International Journal of Molecular Sciences, 24, Article 4925. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Pan, Y., Su, J., Qian, S. and Xu, G. (2024) Impact of Habitual Intake of Glucosamine, Fresh Fruit, and Tea on the Risk of Urolithiasis: A Two-Sample Mendelian Randomization Study. Medicine, 103, e37254. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Rodgers, A.L. and Siener, R. (2020) The Efficacy of Polyunsaturated Fatty Acids as Protectors against Calcium Oxalate Renal Stone Formation: A Review. Nutrients, 12, Article 1069. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Siener, R., Jansen, B., Watzer, B. and Hesse, A. (2011) Effect of N-3 Fatty Acid Supplementation on Urinary Risk Factors for Calcium Oxalate Stone Formation. Journal of Urology, 185, 719-724. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Kantor, E.D., Lampe, J.W., Vaughan, T.L., Peters, U., Rehm, C.D. and White, E. (2012) Association between Use of Specialty Dietary Supplements and C-Reactive Protein Concentrations. American Journal of Epidemiology, 176, 1002-1013. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kantor, E.D., Lampe, J.W., Navarro, S.L., Song, X., Milne, G.L. and White, E. (2014) Associations between Glucosamine and Chondroitin Supplement Use and Biomarkers of Systemic Inflammation. The Journal of Alternative and Complementary Medicine, 20, 479-485. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ye, Z., Xia, Y., Zhou, X., Li, B., Yu, W., Ruan, Y., et al. (2022) CXCR4 Inhibition Attenuates Calcium Oxalate Crystal Deposition-Induced Renal Fibrosis. International Immunopharmacology, 107, Article 108677. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ticinesi, A., Nouvenne, A., Chiussi, G., Castaldo, G., Guerra, A. and Meschi, T. (2020) Calcium Oxalate Nephrolithiasis and Gut Microbiota: Not Just a Gut-Kidney Axis. A Nutritional Perspective. Nutrients, 12, Article 548. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yuan, T., Xia, Y., Li, B., Yu, W., Rao, T., Ye, Z., et al. (2023) Gut Microbiota in Patients with Kidney Stones: A Systematic Review and Meta-Analysis. BMC Microbiology, 23, Article 143.
|
|
[14]
|
Baggio, B., Gambaro, G., Zambon, S., Marchini, F., Bassi, A., Bordin, L., et al. (1996) Anomalous Phospholipid N-6 Polyunsaturated Fatty Acid Composition in Idiopathic Calcium Nephrolithiasis. Journal of the American Society of Nephrology, 7, 613-620. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Rodgers, A., Lewandowski, S., Allie-Hamdulay, S., Pinnock, D., Baretta, G. and Gambaro, G. (2009) Evening Primrose Oil Supplementation Increases Citraturia and Decreases Other Urinary Risk Factors for Calcium Oxalate Urolithiasis. Journal of Urology, 182, 2957-2963. [Google Scholar] [CrossRef] [PubMed]
|